GENOMTEC received a positive evaluation of the National Center for Research and Development (NCBR) as part of the “Fast Track” competition. The company will receive nearly PLN 9 million in subsidies for further development of technology and product. Company develop Genomtec ID – handy, innovative diagnostic device based on the amplification and detection of specific DNA and RNA fragments – the “gold standard” of molecular diagnostics. This technology has a number of implementation possibilities in many areas of medicine, including the so-called liquid biopsy, immunological or biochemical tests.

The grant comes from the European Funds under the Intelligent Development Operational Program, thanks to which the National Center for Research and Development supports innovative solutions for micro, small and medium enterprises.

“With competitions such as the Fast Track, innovative solutions of start-ups like us are able to get a second wind” says Miron Tokarski, CEO of Genomtec.

Congratulations to the Genomtec team. We keep our fingers crossed for success!

Talk – Action = Bullshit